A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

July 23, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Progressive Supranuclear Palsy
Interventions
DRUG

FNP-223

Oral tablets

DRUG

Placebo

Oral tablets

Trial Locations (44)

7623

Pécsi Tudományegyetem Általános Orvostudományi Kar, Pécs

10029

Robert & John M. Bendheim Parkinson and Movement Disorders Center at Mount Sinai, New York

10032

Columbia University Irving Medical Center, New York

13005

Hôpital de la Timone, Marseille

14547

Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson, Beelitz

15006

Complejo Hospitalario Universitario A Coruña, A Coruña

27705

Duke Neurology, Durham

28034

Hospital Universitario Ramón y Cajal, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

30029

L'Hôpital Universitaire Carémeau, Nîmes

30912

Augusta University, Augusta

31008

Hospital Universitario de Navarra, Pamplona

31059

Hôpital Pierre-Paul Riquet, Toulouse

33076

Groupe Hospitalier Pellegrin, Bordeaux

33136

University of Miami Miller School of Medicine, Miami

35128

Azienda Ospedale Università di Padova, Padua

37212

Vanderbilt University Medical Center, Nashville

40139

IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna

40225

Universitätsklinikum Düsseldorf, Düsseldorf

41013

Hospital Universitario Virgen del Rocío, Seville

46086

Hospital Universitari i Politècnic La Fe, Valencia

48334

Quest Research Institute, Farmington Hills

48903

Hospital Universitario Cruces, Barakaldo

56126

Azienda Ospedaliero-Universitaria Pisana, Pisa

75013

Hôpital Universitaire Pitié Salpêtrière, Paris

78681

Central Texas Neurology Consultants, Round Rock

80113

Rocky Mountain Movement Disorders Center, Denver

81377

Ludwig-Maximilians-Universität München (LMU), Munich

84081

Azienda Ospedaliera Universitaria San Giovanni di Dio Ruggi d'Aragona, Salerno

92011

The Neurology Center of Southern California - Carlsbad, Carlsbad

94158

UCSF Weill Institute for Neurosciences, San Francisco

02114

Massachusetts General Hospital, Boston

04103

Universitätsklinikum Leipzig, Leipzig

00163

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - San Raffaele Pisana, Roma

40-571

Neurologia Śląska Centrum Medyczne, Katowice

03-242

Mazowiecki Szpital Bródnowski w Warszawie, Warsaw

4710-243

Hospital de Braga, Braga

2560-280

Campus Neurológico Senior - Torres Vedras, Torres Vedras

08916

Hospital Germans Trias i Pujol, Badalona

08036

Hospital Clínic de Barcelona, Barcelona

CB2 3EB

University of Cambridge, Cambridge

NW1 ePG

University College London Hospitals, London

NE4 5PL

Newcastle Upon Tyne Hospitals, Newcastle

SO16 6YD

University Hospital Southampton, Southampton

All Listed Sponsors
lead

Ferrer Internacional S.A.

INDUSTRY

NCT06355531 - A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) | Biotech Hunter | Biotech Hunter